Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhuocheng Huisheng Biotechnology, operating under the brand U-SENSE, is a prominent Chinese molecular diagnostics company specializing in infectious disease testing. Founded in 2013 and based in Beijing, the company develops and manufactures a comprehensive suite of PCR-based diagnostic kits and automated nucleic acid extraction systems. Their product portfolio addresses critical public health needs, including the detection of respiratory, enteric, vector-borne, and zoonotic pathogens. The company's multiplex PCR technology allows for the simultaneous detection of multiple targets, enhancing diagnostic efficiency in clinical and epidemiological settings. Zhuocheng Huisheng is a key supplier to hospitals and Centers for Disease Control (CDC) across China and has expanded its reach internationally. Backed by leading investors like Qiming Venture Partners and Legend Capital, the company continues to innovate in the field of precision molecular diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Zhuocheng Huisheng Biotechnology.